Aldose reductase inhibitor, fidarestat prevents doxorubicin-induced endothelial cell death and dysfunction

被引:29
|
作者
Sonowal, Himangshu [1 ]
Pal, Pabitra [1 ]
Shukla, Kirtikar [1 ]
Saxena, Ashish [1 ]
Srivastava, Satish K. [1 ]
Ramana, Kota V. [1 ]
机构
[1] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA
关键词
Aldose reductase; Fidarestat; Doxorubicin; Endothelial cells; Cardiotoxicity; BREAST-CANCER PATIENTS; FACTOR-KAPPA-B; NITRIC-OXIDE; INDUCED CARDIOTOXICITY; INDUCED CARDIOMYOPATHY; COLON-CANCER; MOLECULAR-MECHANISMS; UP-REGULATION; IN-VIVO; INFLAMMATION;
D O I
10.1016/j.bcp.2018.02.018
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Despite doxorubicin (Dox) being one of the most widely used chemotherapy agents for breast, blood and lung cancers, its use in colon cancer is limited due to increased drug resistance and severe cardiotoxic side effects that increase mortality associated with its use at high doses. Therefore, better adjuvant therapies are warranted to improve the chemotherapeutic efficacy and to decrease cardiotoxicity. We have recently shown that aldose reductase inhibitor, fidarestat, increases the Dox-induced colon cancer cell death and reduces cardiomyopathy. However, the efficacy of fidarestat in the prevention of Dox-induced endothelial dysfunction, a pathological event critical to cardiovascular complications, is not known. Here, we have examined the effect of fidarestat on Dox-induced endothelial cell toxicity and dysfunction in vitro and in vivo. Incubation of human umbilical vein endothelial cells (HUVECs) with Dox significantly increased the endothelial cell death, and pre-treatment of fidarestat prevented it. Further, fidarestat prevented the Dox-induced oxidative stress, formation of reactive oxygen species (ROS) and activation of Caspase-3 in HUVECs. Fidarestat also prevented Dox-induced monocyte adhesion to HUVECs and expression of ICAM-1 and VCAM-1. Fidarestat pre-treatment to HUVECs restored the Dox-induced decrease in the Nitric Oxide (NO)-levels and eNOS expression. Treatment of HUVECs with Dox caused a significant increase in the activation of NF-kappa B and expression of various inflammatory cytokines and chemokines which were prevented by fidarestat pre-treatment. Most importantly, fidarestat prevented the Doxinduced mouse cardiac cell hypertrophy and expression of eNOS, iNOS, and 3-Nitrotyrosine in the aorta tissues. Further, fidarestat blunted the Dox-induced expression of various inflammatory cytokines and chemokines in vivo. Thus, our results suggest that by preventing Dox-induced endothelial cytotoxicity and dysfunction, AR inhibitors could avert cardiotoxicity associated with anthracycline chemotherapy.
引用
收藏
页码:179 / 188
页数:10
相关论文
共 50 条
  • [41] ALDOSE REDUCTASE AND MYOINOSITOL IN ENDOTHELIAL-CELL DYSFUNCTION CAUSED BY ELEVATED GLUCOSE
    TESFAMARIAM, B
    BROWN, ML
    COHEN, RA
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1992, 263 (01): : 153 - 157
  • [42] An aldose reductase inhibitor partially prevents chronic high glucose-induced impairment of HIT cell functions
    Kishimoto, M
    Kajimoto, Y
    Watada, H
    Matsuoka, T
    Watarai, T
    Kubota, M
    Yamasaki, Y
    DIABETOLOGIA, 1996, 39 : 487 - 487
  • [43] APC Loss Prevents Doxorubicin-Induced Cell Death by Increasing Drug Efflux and a Chemoresistant Cell Population in Breast Cancer
    Stefanski, Casey D. D.
    Arnason, Anne
    Maloney, Sara
    Kotsen, Janna
    Powers, Elizabeth
    Zhang, Jian-Ting
    Prosperi, Jenifer R. R.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)
  • [44] Mechanism of doxorubicin-induced cell death and expression profile analysis
    Lee, S
    Baek, M
    Kim, HY
    Ha, JH
    Jeoung, DI
    BIOTECHNOLOGY LETTERS, 2002, 24 (14) : 1147 - 1151
  • [45] Doxorubicin-induced cell death in highly invasive human gliomas
    Stan, AC
    Casares, S
    Radu, D
    Walter, GF
    Brumeanu, TD
    ANTICANCER RESEARCH, 1999, 19 (2A) : 941 - 950
  • [46] CO and bilirubin inhibit doxorubicin-induced cardiac cell death
    Kim, Do-Sung
    Chae, Soo-Wan
    Kim, Hyung-Ryong
    Chae, Han-Jung
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2009, 31 (01) : 64 - 70
  • [47] FERRITIN INHIBIT DOXORUBICIN-INDUCED BREAST CANCER CELL DEATH
    Buranrat, Benjaporn
    Connor, James R.
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (03) : E65 - E65
  • [48] Mechanism of doxorubicin-induced cell death and expression profile analysis
    Seongeun Lee
    Myungin Baek
    Hae-Yeong Kim
    Ji-Hong Ha
    Doo-Il Jeoung
    Biotechnology Letters, 2002, 24 : 1147 - 1151
  • [50] Autophagy prevents doxorubicin-induced apoptosis in osteosarcoma
    Zhao, Dongxu
    Yuan, Hongping
    Yi, Fei
    Meng, Chunyang
    Zhu, Qingsan
    MOLECULAR MEDICINE REPORTS, 2014, 9 (05) : 1975 - 1981